MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,282,000 | +141.8% | 598,362 | +199.4% | 0.02% | +137.5% |
| Q1 2022 | $17,071,000 | +1161.7% | 199,882 | +2478.1% | 0.01% | +700.0% |
| Q3 2021 | $1,353,000 | -91.1% | 7,753 | -91.7% | 0.00% | -87.5% |
| Q2 2021 | $15,220,000 | +3822.7% | 93,005 | +3900.2% | 0.01% | – |
| Q1 2021 | $388,000 | -73.7% | 2,325 | -67.0% | 0.00% | -100.0% |
| Q4 2020 | $1,477,000 | -27.7% | 7,049 | -40.8% | 0.00% | -50.0% |
| Q3 2020 | $2,043,000 | +186.5% | 11,908 | +93.4% | 0.00% | +100.0% |
| Q2 2020 | $713,000 | -71.1% | 6,156 | -81.2% | 0.00% | -66.7% |
| Q1 2020 | $2,468,000 | -7.1% | 32,741 | +58.8% | 0.00% | +50.0% |
| Q4 2019 | $2,657,000 | +44.5% | 20,616 | -12.7% | 0.00% | 0.0% |
| Q3 2019 | $1,839,000 | +669.5% | 23,610 | +919.4% | 0.00% | – |
| Q2 2019 | $239,000 | +1891.7% | 2,316 | +712.6% | 0.00% | – |
| Q4 2018 | $12,000 | +71.4% | 285 | +105.0% | 0.00% | – |
| Q3 2018 | $7,000 | +16.7% | 139 | +7.8% | 0.00% | – |
| Q2 2018 | $6,000 | – | 129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |